Background
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). It is derived from a murine monoclonal antibody, which was humanized to produce Omalizumab in its present form. It contains 5% non-human (murine) amino acid residues, which make up the complementarity determining regions (CDRs) of the protein.Antibodysystem Anti-Omalizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Omalizumab.